Pea (Pisum sativum L.) protease inhibitors from the Bowman - Birk class influence the growth of human colorectal adenocarcinoma HT29 cells in vitro

Journal of Agricultural and Food Chemistry

Volumn 53, Issue 23, 2005, Pages 8979-8986

  Clemente, Alfonso ^a,c   Gee, Jennifer M ^b   Johnson, Ian T ^b   MacKenzie, Donald A ^b   Domoney, Claire ^a  

^a JOHN INNES CENTRE   (United Kingdom)

^b INSTITUTE OF FOOD RESEARCH   (United Kingdom)

^c CSIC   (Spain)

Author keywords

Bowman Birk inhibitor; Cell growth; Chymotrypsin inhibitory domain; Colon cancer cells; Pea; Pisum sativum

Indexed keywords

BOWMAN BIRK INHIBITOR; PROTEINASE INHIBITOR; RECOMBINANT PROTEIN;

ADENOCARCINOMA; AMINO ACID SEQUENCE; ARTICLE; CELL DIVISION; CELL STRAIN HT29; CHEMISTRY; COLORECTAL TUMOR; COMPARATIVE STUDY; DRUG EFFECT; HUMAN; MOLECULAR GENETICS; PATHOLOGY; PEA; PLANT SEED;

ADENOCARCINOMA; AMINO ACID SEQUENCE; CELL DIVISION; COLORECTAL NEOPLASMS; HT29 CELLS; HUMANS; MOLECULAR SEQUENCE DATA; PEAS; PROTEASE INHIBITORS; RECOMBINANT PROTEINS; SEEDS; TRYPSIN INHIBITOR, BOWMAN-BIRK SOYBEAN;

GLYCINE MAX; PISUM SATIVUM;

EID: 28444443440     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf051528w     Document Type: Article

References (39)

1. Kennedy, A. R. Chemopreventive agents: Protease inhibitors. Pharmacol. Ther. 1998, 78, 167-209.
2. Kennedy, A. R.; Szuhaj, B. F.; Newberne, P. M.; Billings, P. C. Preparation and production of a cancer chemopreventive agent, Bowman - Birk inhibitor concentrate. Nutr. Cancer 1993, 19, 281-302.
3. Armstrong, W. B.; Kennedy, A. R.; Wan, X. S.; Taylor, T. H.; Nguyen, Q. A.; Jensen, J.; Thompson, W.; Lagerberg, W.; Meyskens, F. L. Clinical modulation of oral leukoplakia and protease activity by Bowman - Birk inhibitor concentrate in a phase IIa chemoprevention trial. Clin. Cancer Res. 2000, 6, 4684-4691.
4. Zhang, L. L.; Wan, X. S.; Donahue, J. J.; Ware, J. H.; Kennedy, A. R. Effects of the Bowman - Birk inhibitor on clonogenic survival and cisplatin- or radiation-induced cytotoxicity in human breast, cervical, and head and neck cancer cells. Nutr. Cancer 1999, 33, 165-173.
5. Armstrong, W. B.; Kennedy, A. R.; Wan, X. S.; Atiba, J.; McLaren, C. E.; Meyskens, F. L. Single-dose administration of Bowman - Birk inhibitor concentrate in patients with oral leukoplakia. Cancer Epidemiol., Biomarkers Prev. 2000, 9, 43-47.
6. Birk, Y. The Bowman - Birk inhibitor: Trypsin and chymotrypsin inhibitor from soybeans. Int. J. Pept. Protein Res. 1985, 25, 113-131.
7. Yavelow, J.; Finlay, T. H.; Kennedy, A. R.; Troll, W. Bowman - Birk soybean protease inhibitor as an anticarcinogen. Cancer Res. 1983, 43, 2454-2459.
8. Billings, P. C.; St. Clair, W.; Maki, P. A.; Kennedy, A. R. Distribution of the Bowman - Birk protease inhibitor in mice following oral administration. Cancer Lett. 1992, 62, 191-197.
9. Billings, P. C.; Brandon, D. L.; Habres, J. M. Internalization of the Bowman - Birk protease inhibitor by intestinal epithelial cells. Eur. J. Cancer 1991, 27, 903-908.
10. Kennedy, A. R.; Billings, P. C.; Wan, S.; Newberne, P. M. Effects of Bowman - Birk inhibitor on rat colon carcinogenesis. Nutr. Cancer 2002, 43, 174-186.
11. Fernandes, A. O.; Banerji, A. P. Inhibition of benzopyrene-induced forestomach tumors by field bean protease inhibitor(s). Carcinogenesis 1995, 16, 1843-1846.
12. Lee, S. L.; Dickson, R. B.; Lin, C. Y. Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease. J. Biol. Chem. 2000, 275, 36720-36725.
13. Darmoul, D.; Gratio, V.; Devaud, H.; Lehy, T.; Laburthe, M. Aberrant expression and activation of the thrombin receptor protease-activated receptor-1 induces cell proliferation and motility in human colon cancer cells. Am. J. Pathol. 2003, 162, 1503-1513.
14. Yavelow, J.; Collins, M.; Birk, Y.; Troll, W.; Kennedy, A. R. Nanomolar concentrations of Bowman - Birk soybean protease inhibitor suppress X-ray induced transformation in vitro. Proc. Natl. Acad. Sci. U.S.A. 1985, 82, 5395-5399.
15. Gueven, N.; Dittmann, K.; Mayer, C.; Rodemann H. P. The radioprotective potential of the Bowman - Birk protease inhibitor is independent of its secondary structure. Cancer Lett. 1998, 125, 77-82.
16. Shewry, P. R. Enzyme inhibitors of seeds: Types and properties. In Seed Proteins; Shewry, P. R., Casey, R., Eds.; Kluwer Academic, Dordrecht, The Netherlands, 1999; pp 587-615.
17. Clemente, A.; MacKenzie, D. A.; Jeenes, D. J.; Domoney, C. The effect of variation within inhibitory domains on the activity of pea protease inhibitors from the Bowman - Birk class. Protein Expression Purif. 2004, 36, 106-114.
18. Sakamoto, K.; Venkatraman, G.; Shamsuddin, A. M. Growth-inhibition and differentiation of HT-29 cells in vitro by inositol hexaphosphate (phytic acid). Carcinogenesis 1993, 14 1815-1819.
19. Domoney, C.; Welham, T.; Sidebottom, C. Purification and characterization of Pisum seed trypsin inhibitors. J. Exp. Bot. 1993, 44, 701-709.
20. Domoney, C.; Welham, T. Trypsin inhibitors in Pisum: Variation in amount and pattern of accumulation in developing seed. Seed Sci. Res. 1992, 2, 147-154.
21. Domoney, C. Inhibitors of legume seeds. In Seed Proteins; Shewry, P. R., Casey, R., Eds.; Kluwer Academic Pubs, Dordrecht, The Netherlands, 1999; pp 635-655.
22. Page, D.; Aubert, G.; Duc, G.; Domoney, C. Combinatorial variation in coding and promoter sequences of genes at the Tri locus in Pisum sativum accounts for variation in trypsin inhibitor activity in seeds, Mol. Genet. Genomics 2002, 267, 359-369.
23. Longthorne, V. L.; Williams, G. T. Caspase activity is required for commitment to Fas-mediated apoptosis. EMBO J. 1997, 16, 3805-3812.
24. MacFarlane, M.; Cain, K.; Sun, X. M.; Alnemri, E. S.; Cohen, G. M. Processing/activation of at least four interleukin-1 β converting enzyme-like proteases occurs during the execution phase of apoptosis in human monocytic tumor cells. J. Cell Biol. 1997, 137, 469-479.
25. Foehr, M. W.; Tomei, L. D.; Goddard, J. G.; Pemberton, P. A.; Bathurst, I. C. Antiapoptotic activity of the Bowman - Birk inhibitor can be attributed to copurified phospholipids. Nutr. Cancer 1999, 34, 199-205.
26. Domoney, C.; Welham, T.; Sidebottom, C.; Firmin, J. L. Multiple isoforms of Pisum trypsin inhibitors result from modification of two primary gene products. FEBS Lett. 1995, 360, 15-20.
27. Schechter, I.; Berger, A. On the size of the active site in proteases. I. Papain. Biochem. Biophys. Res. Commun. 1967, 27, 157-162.
28. de la Sierra, I.; Quillien, L.; Flecker, P.; Gueguen, J.; Brunie, S. Dimeric crystal structure Bowman - Birk protease inhibitor from pea seeds. J. Mol. Biol. 1999, 285, 1195-1207.
29. Kumar, P.; Sreerama, Y. N.; Gowda, L. R. Formation of Bowman - Birk inhibitors during the germination of horsegram (Dolichos biflorus). Phytochemistry 2002, 60, 581-588.
30. Piergiovanni, A. R.; Galasso, I. Polymorphism of trypsin and chymotrypsin binding loops in Bowman - Birk inhibitors from common bean (Phaseolus vulgaris L.). Plant Sci. 2004, 166, 1525-1531.
31. McBride, J. D.; Freeman, H. N.; Domingo, G. J.; Leatherbarrow, R. J. Selection of chymotrypsin inhibitors from a conformationally constrained combinatorial peptide library. J. Mol Biol. 1996, 259, 819-827.
32. McBride, J. D.; Freeman, H. N.; Leatherbarrow, R. J. Identification of chymotrypsin inhibitors from a second-generation template assisted combinatorial peptide library. J. Peptide Sci. 2000, 6, 446-452.
33. Perona, J. J.; Craik, C. S. Structural basis of substrate specificity in the serine proteases. Protein Sci. 1995, 4, 337-360.
34. Lu, W.; Apostol, I.; Qasim, M. A.; Warne, N.; Wynn, R.; Zhang, W. L.; Anderson, S.; Chiang, Y. W.; Ogin, E.; Rothberg, I.; Ryan, K.; Laskowski Jr. M. Binding of amino acid side-chains to Si cavities of serine proteases. J. Mol. Biol. 1997, 266, 441-461.
35. Koepke, J.; Ermler, U.; Warkentin, E.; Wezl, G.; Flecker, P. Crystal structure of cancer chemopreventive Bowman - Birk inhibitor in ternary complex with bovine trypsin at 2.3 Å resolution. Structural basis of Janus-faced serine protease inhibitor specificity. J. Mol. Biol. 2000, 298, 477-491.
36. Garcia-Gasca, T.; Salazar-Olivo, L. A.; Mendiola-Olaya, E.; Blanco-Labra, A. The effects of a protease inhibitor fraction from tepary bean (Phaseolus acutifolius) on in vitro cell proliferation and cell adhesion of transformed cells. Toxicol. in Vitro 2002, 16, 229-233.
37. McKerrow, J. H.; Bhargava, V.; Hansell, E.; Huling, S.; Kuwahara, T.; Matley, M.; Coussens, L.; Warren, R. A functional proteomics screen of proteases in colorectal carcinoma. Mol. Med. 2000, 6, 450-460.
38. Yamasaki, Y.; Satomi, S.; Murai, N.; Tsuzuki, S.; Fushiki, T. Inhibition of membrane-type serine protease 1/matriptase by natural and synthetic protease inhibitors. J. Nutr. Sci. Vitaminol. 2003, 49, 27-32.
39. Takeuchi, T.; Harris, J. L.; Huang, W.; Yan, K. W.; Coughlin, S. R.; Craik, C. S. Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates. J. Biol. Chem. 2000, 275, 26333-26342.